Outcomes from Gleason 7, intermediate risk, localized prostate cancer treated with Iodine-125 monotherapy over 10years-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcomes from Gleason 7, intermediate risk, localized prostate cancer treated with Iodine-125 monotherapy over 10years

Published:2010-07 Issue:1 Volume:96 Page:34-37
ISSN:0167-8140
Container-title:Radiotherapy and Oncology
language:en
Short-container-title:Radiotherapy and Oncology

Author:

Munro Nicholas P.,Al-Qaisieh Bashar,Bownes Peter,Smith Jonathan,Carey Brendan,Bottomley David,Ash Dan,Henry Ann M.

Publisher

Elsevier BV

Subject

Radiology Nuclear Medicine and imaging,Oncology,Hematology

Reference14 articles.

1. Outcomes following Iodine-125 monotherapy for localized prostate cancer: the results of Leeds ten year single centre brachytherapy experience;Henry;Int J Radiat Oncol Biol Phys,2010

2. Primary Gleason pattern does not impact survival after permanent interstitial brachytherapy for Gleason score 7 prostate cancer;Merrick;Cancer,2007

3. The prognostic significance of Gleason Grade in patients treated with permanent prostate brachytherapy;Potters;Int J Radiat Oncol Biol Phys,2003

4. Comparison of biochemical relapse-free survival between primary Gleason score 3 and primary Gleason score 4 for biopsy Gleason score 7 prostate cancer;Burdick;Int J Radiat Oncol Biol Phys,2009

5. Consensus statement. Guidelines for PSA following radiation therapy;Int J Radiat Oncol Biol Phys,1997

Cited by 38 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Langzeitauswertung der Low-dose-rate(LDR)-Brachytherapie des lokal begrenzten Prostatakarzinoms;Die Urologie;2023-05-31

2. Assessing the role of external beam radiation therapy in combination with brachytherapy versus brachytherapy alone for unfavorable intermediate-risk prostate cancer;Brachytherapy;2022-05

3. Comparison of EBRT and I-125 seed brachytherapy concerning outcome in intermediate-risk prostate cancer;Strahlentherapie und Onkologie;2021-08-05

4. Eligibility criteria according to EAU/ESTRO/SIOG guidelines for exclusive iodine-125 brachytherapy for intermediate-risk prostate adenocarcinoma patients: impact on relapse-free survival;Journal of Contemporary Brachytherapy;2021

5. Literatur zu Giordano/Wenz: Strahlentherapie kompakt, 3. Auflage;Strahlentherapie kompakt;2019

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3